The Prevalence of blaNDM-1 in Clinical Isolates of Carbapenem-resistant Pseudomonas Aeruginosa: A Systematic Review

Background: Pseudomonas aeruginosa (P. aeruginosa) is a gram negative bacteria that is known to cause nosocomial infections. Carbapenem is used to treat the damage caused by P. aeruginosa, however it is becoming resistant to carbapenems because of the production of β-lactamases. The objectives of th...

Full description

Bibliographic Details
Main Authors: Bea Jorelli U. Fernando, Ma. Oryza B. Antonio, Ken Matthew A. De Guzman, Jan Carlo Y. Gatbonton, Sunshine T. Vendivil, Raphael Enrique G. Tiongco, Sherill D. Tesalona
Format: Article
Language:English
Published: Ital Publication 2021-12-01
Series:SciMedicine Journal
Subjects:
Online Access:https://www.scimedjournal.org/index.php/SMJ/article/view/386
_version_ 1811190543173025792
author Bea Jorelli U. Fernando
Ma. Oryza B. Antonio
Ken Matthew A. De Guzman
Jan Carlo Y. Gatbonton
Sunshine T. Vendivil
Raphael Enrique G. Tiongco
Sherill D. Tesalona
author_facet Bea Jorelli U. Fernando
Ma. Oryza B. Antonio
Ken Matthew A. De Guzman
Jan Carlo Y. Gatbonton
Sunshine T. Vendivil
Raphael Enrique G. Tiongco
Sherill D. Tesalona
author_sort Bea Jorelli U. Fernando
collection DOAJ
description Background: Pseudomonas aeruginosa (P. aeruginosa) is a gram negative bacteria that is known to cause nosocomial infections. Carbapenem is used to treat the damage caused by P. aeruginosa, however it is becoming resistant to carbapenems because of the production of β-lactamases. The objectives of the study were to systematically review the prevalence of blaNDM-1 in carbapenem-resistant Pseudomonas aeruginosa (CRPA) and to review and analyze the clinical sources as well as the antibiotic resistance profile of CRPA carrying blaNDM-1. Methods: The researchers systematically searched PubMed, ScienceDirect, and Google Scholar. Studies that met the inclusion criteria were included in the review. In assessing the methodological quality of the included studies, the JBI Critical Appraisal Checklist for Studies Reporting Prevalence Data and the JBI Critical Appraisal Checklist for Case Reports were used. Results: A total of nine studies were included in which eight were cross-sectional studies and one was a case report. The highest prevalence rate reported was 54.55% in blaNDM-1 positive CRPA isolates among the cross-sectional studies. The three most frequent sources of clinical isolates of CRPA carrying blaNDM-1 include urine, wound discharge, and tissue, among the included studies. Lastly, this review showed that among the included studies, CRPA isolates carrying blaNDM-1 were most resistant to ceftazidime and gentamicin. Conclusions: There is varying prevalence of blaNDM-1 in CRPA in different countries. Urine, wound discharge, and tissue specimens being the most frequent sources of CRPA isolates carrying blaNDM-1 poses a challenge that must be given attention by the  infection control committee, thus the need for proper handling and processing of clinical specimens. Resistance to ceftazidime and gentamicin among the CRPA isolates carrying blaNDM-1highlights the growing challenge of successfully treating infections caused by this bacteria. This challenge reminds us of the importance and purpose of antibiotic stewardship that emphasizes the improvement of proper antibiotic prescription by the physicians and proper antibiotic use by the patients that can help in preventing harm and antibiotic resistance.   Doi: 10.28991/SciMedJ-2021-0304-9 Full Text: PDF
first_indexed 2024-04-11T14:51:47Z
format Article
id doaj.art-7bbc81a2e65b4b9b8bc6dbba6f5200e4
institution Directory Open Access Journal
issn 2704-9833
language English
last_indexed 2024-04-11T14:51:47Z
publishDate 2021-12-01
publisher Ital Publication
record_format Article
series SciMedicine Journal
spelling doaj.art-7bbc81a2e65b4b9b8bc6dbba6f5200e42022-12-22T04:17:23ZengItal PublicationSciMedicine Journal2704-98332021-12-013438739810.28991/SciMedJ-2021-0304-9105The Prevalence of blaNDM-1 in Clinical Isolates of Carbapenem-resistant Pseudomonas Aeruginosa: A Systematic ReviewBea Jorelli U. Fernando0Ma. Oryza B. Antonio1Ken Matthew A. De Guzman2Jan Carlo Y. Gatbonton3Sunshine T. Vendivil4Raphael Enrique G. Tiongco5Sherill D. Tesalona6Department of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, España Blvd, Sampaloc, Manila,Department of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, España Blvd, Sampaloc, Manila,Department of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, España Blvd, Sampaloc, Manila,Department of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, España Blvd, Sampaloc, Manila,Department of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, España Blvd, Sampaloc, Manila,Department of Medical Technology, College of Allied Medical Professions, Angeles University Foundation, Angeles City,Department of Medical Technology, Faculty of Pharmacy, University of Santo Tomas, España Blvd, Sampaloc, Manila,Background: Pseudomonas aeruginosa (P. aeruginosa) is a gram negative bacteria that is known to cause nosocomial infections. Carbapenem is used to treat the damage caused by P. aeruginosa, however it is becoming resistant to carbapenems because of the production of β-lactamases. The objectives of the study were to systematically review the prevalence of blaNDM-1 in carbapenem-resistant Pseudomonas aeruginosa (CRPA) and to review and analyze the clinical sources as well as the antibiotic resistance profile of CRPA carrying blaNDM-1. Methods: The researchers systematically searched PubMed, ScienceDirect, and Google Scholar. Studies that met the inclusion criteria were included in the review. In assessing the methodological quality of the included studies, the JBI Critical Appraisal Checklist for Studies Reporting Prevalence Data and the JBI Critical Appraisal Checklist for Case Reports were used. Results: A total of nine studies were included in which eight were cross-sectional studies and one was a case report. The highest prevalence rate reported was 54.55% in blaNDM-1 positive CRPA isolates among the cross-sectional studies. The three most frequent sources of clinical isolates of CRPA carrying blaNDM-1 include urine, wound discharge, and tissue, among the included studies. Lastly, this review showed that among the included studies, CRPA isolates carrying blaNDM-1 were most resistant to ceftazidime and gentamicin. Conclusions: There is varying prevalence of blaNDM-1 in CRPA in different countries. Urine, wound discharge, and tissue specimens being the most frequent sources of CRPA isolates carrying blaNDM-1 poses a challenge that must be given attention by the  infection control committee, thus the need for proper handling and processing of clinical specimens. Resistance to ceftazidime and gentamicin among the CRPA isolates carrying blaNDM-1highlights the growing challenge of successfully treating infections caused by this bacteria. This challenge reminds us of the importance and purpose of antibiotic stewardship that emphasizes the improvement of proper antibiotic prescription by the physicians and proper antibiotic use by the patients that can help in preventing harm and antibiotic resistance.   Doi: 10.28991/SciMedJ-2021-0304-9 Full Text: PDFhttps://www.scimedjournal.org/index.php/SMJ/article/view/386antibiotic resistanceblandm-1carbapenem-resistantmetallo-beta-lactamasepseudomonas aeruginosa.
spellingShingle Bea Jorelli U. Fernando
Ma. Oryza B. Antonio
Ken Matthew A. De Guzman
Jan Carlo Y. Gatbonton
Sunshine T. Vendivil
Raphael Enrique G. Tiongco
Sherill D. Tesalona
The Prevalence of blaNDM-1 in Clinical Isolates of Carbapenem-resistant Pseudomonas Aeruginosa: A Systematic Review
SciMedicine Journal
antibiotic resistance
blandm-1
carbapenem-resistant
metallo-beta-lactamase
pseudomonas aeruginosa.
title The Prevalence of blaNDM-1 in Clinical Isolates of Carbapenem-resistant Pseudomonas Aeruginosa: A Systematic Review
title_full The Prevalence of blaNDM-1 in Clinical Isolates of Carbapenem-resistant Pseudomonas Aeruginosa: A Systematic Review
title_fullStr The Prevalence of blaNDM-1 in Clinical Isolates of Carbapenem-resistant Pseudomonas Aeruginosa: A Systematic Review
title_full_unstemmed The Prevalence of blaNDM-1 in Clinical Isolates of Carbapenem-resistant Pseudomonas Aeruginosa: A Systematic Review
title_short The Prevalence of blaNDM-1 in Clinical Isolates of Carbapenem-resistant Pseudomonas Aeruginosa: A Systematic Review
title_sort prevalence of blandm 1 in clinical isolates of carbapenem resistant pseudomonas aeruginosa a systematic review
topic antibiotic resistance
blandm-1
carbapenem-resistant
metallo-beta-lactamase
pseudomonas aeruginosa.
url https://www.scimedjournal.org/index.php/SMJ/article/view/386
work_keys_str_mv AT beajorelliufernando theprevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT maoryzabantonio theprevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT kenmatthewadeguzman theprevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT jancarloygatbonton theprevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT sunshinetvendivil theprevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT raphaelenriquegtiongco theprevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT sherilldtesalona theprevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT beajorelliufernando prevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT maoryzabantonio prevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT kenmatthewadeguzman prevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT jancarloygatbonton prevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT sunshinetvendivil prevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT raphaelenriquegtiongco prevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview
AT sherilldtesalona prevalenceofblandm1inclinicalisolatesofcarbapenemresistantpseudomonasaeruginosaasystematicreview